In addition, it has been reported that inactivation of SMAD family member 4 (SMAD4) and cyclin dependent kinase inhibitor 2A (CDKN2A) is related to the development of pancreatic cancer (Pihlak et al., 2018). The gene discussed is SMAD4; the disease is familial pancreatic carcinoma.